Table 1 Clinicopathological characteristics and GAS5 expression in 89 patient samples of gastric cancer
Clinical parameter | Number of cases (%) |
|---|---|
Age (years) | Â |
<50 | 46 (51.7) |
>50 | 43 (48.3.) |
Gender | Â |
Male | 53 (59.6) |
Female | 36 (40.4) |
Location | Â |
Distal | 36 (40.4) |
Middle | 35 (39.3) |
Proximal | 18 (20.2) |
Size | Â |
>5Â cm | 44 (49.4) |
<5Â cm | 45 (50.6) |
Histologic differentiation | Â |
Well | 6 (6.7) |
Moderately | 30 (33.7) |
Poorly | 43 (48.3) |
Undifferentiatedly | 10 (11.2) |
Invasion depth | Â |
T1 | 21 (23.6) |
T2 | 26 (29.2) |
T3 | 23 (25.8) |
T4 | 19 (21.3) |
TNM Stages | Â |
I | 15 (16.9) |
II | 34 (38.2) |
III | 35 (39.3) |
IV | 5 (5.6) |
Lymphatic metastasis | Â |
Yes | 44 (49.4) |
No | 45 (50.6) |
Regional lymph nodes | Â |
PN0 | 45 (50.6) |
PN1 | 16 (18.0) |
PN2 | 18 (20.2) |
PN3 | 10 (11.2) |
Distant metastasis | Â |
Yes | 4 (4.5) |
No | 85 (95.5) |
Expression of GAS5 | Â |
Low expression | 44 (49.4) |
High expression | 45 (50.6) |